Skip to content
★ Sign in to follow
BP

Birzeit Pharmaceuticals Stock: price and insider trades · Palestine

1 insider bought shares over the last 90 days, the latest by فهيم حسن حسين زبيدي, filed 24 Aug 2026.

Insider Decl.
47
Thresholds
n/a
Buy Volume
n/a
32 ops. · all time
Sell Volume
n/a
15 ops. · all time

Birzeit Pharmaceuticals: what insiders have been doing

Every trade that managers of Birzeit Pharmaceuticals disclose to PCMA / Palestine Exchange is tracked on this page. Over the twelve months to 15 November 2026, 19 filings were filed, from 9 insiders.

On the market, 5 insiders bought (12 purchases) while 6 insiders sold (7 sales). The totals exclude 19 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 3 board members and 1 senior executive among the declarants.

The clock since the last published purchase (24 August 2026) now reads 85 days.

Across the 51 companies tracked on its exchange, the median is 9 filings; at 19 filings, this issuer sits above that mark. Our records for Birzeit Pharmaceuticals go back to 2018, with 32 purchases and 15 sales on the open market in total.

This summary is built from PCMA / Palestine Exchange disclosures alone and does not predict where the share price will go.

Who traded when

BuySale
لوتس للاستثمارات المالية5 buys2 sales
فهيم حسن حسين زبيدي4 buys1 sale
محمد"حسين" اياد كاظم ناصرالدين3 sales
شركة اسواق للمحافظ الاستثمارية2 buys
شركة جراند فارم للاستثمارات الصيدلانية2 buys
ص توفير عمال وموظفي شركة بيرزيت للادوية1 buy

+3 other insiders

Financial data

· cache

Last declaration on 24 August 2026

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations47 total

25 of 47 declarations

About Birzeit Pharmaceuticals

Birzeit Pharmaceuticals is a pharmaceutical company based in Palestine, specializing in the production of generic drugs and pharmaceutical products. It aims to improve access to healthcare in the region.

Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.